The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
C | Cardiovascular system | |
2
|
C02 | Antihypertensives | |
3
|
C02K | Other antihypertensives | |
4
|
C02KN | Other antihypertensives | |
5
|
C02KN02 |
| Active Ingredient |
|---|
|
Baxdrostat is an inhibitor of human aldosterone synthase. Aldosterone contributes to hypertension by promoting the retention of sodium and water by the kidneys, which increases blood volume and, consequently, raises blood pressure. Aldosterone can cause vascular dysfunction, inflammation, and fibrosis. Inhibition of aldosterone synthase by baxdrostat decreases plasma aldosterone concentrations, thereby reducing blood pressure. |
| Document | Type | Information Source | |
|---|---|---|---|
| BAXFENDY Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |